Cause of Early-Onset CRC? Congressman’s Mysterious Absence; Med School Program Sued

Note that some links may require registration or subscription.

Scientists are researching what role the gut’s microbiome may have in the recent rise in colorectal cancer among young adults. (NPR)

Rep. Thomas Kean, Jr. (R-N.J.), who has been absent from Congress for nearly 2 months, disclosed that he expects to make a full recovery from a “personal medical issue,” but offered no further information about his health or timeline of his return. (New York Times)

Purdue Pharma will be sentenced for its role in the opioid epidemic, completing a plea deal that enables the company to dissolve in bankruptcy and use its assets to fund a $7.4 billion settlement. (Reuters)

The Trump administration reiterated its stance on harm reduction services for people who use illicit drugs, issuing warnings to not use federal funds for sterile syringes or fentanyl test strips. (STAT)

The Supreme Court appeared divided as it heard oral arguments in a case involving thousands of lawsuits that alleged Roundup weedkiller causes cancer. (New York Times)

The U.S. reported 37 new measles cases in the past week, according to the Yale School of Public Health. Here’s where they were.

Public health officials in several states are investigating an outbreak of Salmonella illnesses linked to contact with backyard poultry, the CDC said.

A federal program that helped Native Hawaiian medical students for 35 years is being sued over alleged discrimination. (The Guardian)

Hospitals that treat patients who require extended stays are shuttering. (Axios)

Media and health information preferences were key correlates of measles, mumps, and rubella vaccine hesitancy, a survey study showed. (Vaccine)

The FDA approved anifrolumab (Saphnelo) as a once-weekly autoinjector to treat adults with systemic lupus erythematosus on top of standard therapy, AstraZeneca announced.

The agency also expanded the indication for lumateperone (Caplyta) to prevent relapse in schizophrenia, Johnson & Johnson said.

The FDA took issue with promotional claims made by Incyte about its chronic graft-versus-host disease treatment axatilimab (Niktimvo). (Fierce Pharma)

As war raged around him, this orthopedic surgeon kept a Sudan hospital functioning. (AP)

A woman with lupus worried whether she could carry her baby to term. (New York Times)

In South Florida, a 52-year-old mother of three is set to graduate from medical school. (WPLG)